Recruiting Cervical Cancer Studies in Augusta
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
This is a phase III, randomized, double-blind, placebo-controlled, multi-center, global study to explore the efficacy and safety of volrustomig in women with high-risk LACC (FIGO 2018 stage IIIA to IV...
Pembrolizumab and Lenvatinib in Advanced Cervical Cancer
This is a phase II trial of combination therapy of pembrolizumab and lenvatinib in patients with locally advanced or metastatic cervical cancer that had failed first line of therapy. The hypothesis is...
About Cervical Cancer Clinical Trials in Augusta
Cervical cancer develops in the cervix and is primarily caused by persistent HPV infection. It is one of the most preventable cancers through HPV vaccination and screening. Treatment includes surgery, radiation, chemotherapy, and immunotherapy for advanced cases.
There are currently 2 cervical cancer clinical trials recruiting participants in Augusta, GA. These studies are seeking a combined 835 participants. Research is being sponsored by AstraZeneca, Georgetown University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Cervical Cancer Clinical Trials in Augusta — FAQ
Are there cervical cancer clinical trials in Augusta?
Yes, there are 2 cervical cancer clinical trials currently recruiting in Augusta, GA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Augusta?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Augusta research site will contact you about next steps.
Are clinical trials in Augusta free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Augusta studies also compensate for your time and travel.
What cervical cancer treatments are being tested?
The 2 active trials in Augusta are testing new therapies including novel drugs, biologics, and treatment approaches for cervical cancer.
Data updated March 2, 2026 from ClinicalTrials.gov